Table 1 Summary of reported cases of peritoneal metastasis of prostate cancer
From: Peritoneal dissemination of prostate cancer due to laparoscopic radical prostatectomy: a case report
Authors | Age | Initial PSA (ng/mL) | Gleason score | Initial TNM | Treatment before detection of the peritoneal metastasis | PSA at the diagnosis of peritoneal metastasis (ng/mL) | Treatment after the diagnosis of peritoneal metastasis | Follow-up after the diagnosis of peritoneal metastasis |
|---|---|---|---|---|---|---|---|---|
Kehinde et al. [2] | 76 | 365 | 4+4, mucinous adenocarcinoma | T3(?)N0M1 | - | 365 | Hormone therapy | 18 months, AED |
Brehmer et al. [3] | 75 | 42 | 4+5 | T3N0M1 | - | 42 | Hormone therapy | 14 months, AED |
Zagouri et al. [4] | 75 | 33 | 4+5 | T×N0M0 | Hormone therapy for 72 months | 74 | Docetaxel + estramustine phosphate | 18 months, AED |
Present case | 69 | 9.5 | 4+4 | T3aN0M0 | Radical prostatectomy, salvage radiotherapy, and hormone therapy for 89 months | 168 | Palliative | 6 months, DOD |